Overview / Abstract: |
Target Audience This activity has been designed to address the educational needs of neurologists, emergency room physicians, and hospital clinicians (including hospitalists, nurse practitioners, PAs, and clinical pharmacists). It may also benefit other health care providers caring for patients at risk for acute ischemic stroke (AIS). Program Overview Faculty members who are expert in all aspects of the management of acute ischemic stroke use case scenarios to contextualize current guideline recommendations and emerging data related to thrombolysis in patients who have large vessel occlusion stroke, wake-up stroke, and mild stroke. The faculty also addresses important aspects of collaborative care and optimizing technology for telestroke in appropriate settings. Learning Objectives Upon completion of this activity, participants should be better able to: Summarize the latest data from clinical trials of thrombolytic agents used in the treatment of AIS |
Expiration |
Sep 01, 2023 |
Discipline(s) |
Pharmacy CPE, Physician CME |
Format |
Online |
Credits / Hours |
1.25 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Peter D. Panagos, MD Jose G. Romano, MD |
Sponsors / Supporters / Grant Providers |
Genentech, a member of the Roche Group. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Ischemic, Stroke Free CE CME |